Cargando…

P410 The impact of the COVID 19 pandemic and modulator therapy on routine respiratory sampling in paediatric cystic fibrosis (CF)

Detalles Bibliográficos
Autores principales:	Millman, B., Leach, N., Hine, C., Nagakumar, P., Davies, B., Desai, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. Published by Elsevier B.V. 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250892/ http://dx.doi.org/10.1016/S1569-1993(23)00780-4

Ejemplares similares

76: Sustaining routine cystic fibrosis care in a large pediatric CF program during COVID-19
por: Gordon, R., et al.
Publicado: (2021)

P256 Impact of COVID-19 pandemic and introduction of CFTR modulator therapy on sputum sampling in a large adult cystic fibrosis (CF) unit
por: Gaffney, K., et al.
Publicado: (2023)

72: Development of a decision aid for adult-diagnosed cystic fibrosis in a community hospital CF program
por: Belkin, R., et al.
Publicado: (2021)

68 Respiratory viral detection in children with cystic fibrosis (CF)
por: Tješić-Drinković, I., et al.
Publicado: (2015)

410: Pseudomonas aeruginosa modulates SARS-CoV-2 infectivity in CF airway epithelial cells by increasing expression of the host protease TMPRSS2
por: Ruffin, M., et al.
Publicado: (2021)

Improving the care of patients with cystic fibrosis (CF)
por: Khan, Ahsan Aftab, et al.
Publicado: (2017)

ePS4.07 COVID-19 early vaccination campaign in Italian cystic fibrosis (CF) patients: the experience of the Italian Society for the Study of Cystic Fibrosis (SIFC)
por: Lucca, F., et al.
Publicado: (2022)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)
por: Wen, Hongjie, et al.
Publicado: (2020)

PIV-23 Clinical usefulness of HMPV quantitative PCR in paediatric respiratory samples
por: Verroken, A., et al.
Publicado: (2009)

P230 A review of paediatric cystic fibrosis care during the COVID-19 pandemic
por: Powell, L., et al.
Publicado: (2021)

P072 SARS-CoV-2 infection in patients with cystic fibrosis (CF) - a single centre experience
por: Vidoevska, A., et al.
Publicado: (2022)

490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study
por: Blanchard, A., et al.
Publicado: (2021)

Evaluation of tests to predict metallo-β-lactamase in cystic fibrosis (CF) and non-(CF) Pseudomonas
por: Perez, Leandro Reus Rodrigues, et al.
Publicado: (2014)

Rehabilitation Programs for Cystic Fibrosis – View from a CF Center
por: Griese, M, et al.
Publicado: (2010)

433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study
por: Hernandez, R., et al.
Publicado: (2021)

ePS4.09 COVID-19 vaccination in households of paediatric cystic fibrosis patients - experience of The Cystic Fibrosis Centre in Zagreb, Croatia
por: Bambir, I., et al.
Publicado: (2022)

1602. Comparative Activity of Ceftolozane-Tazobactam (C/T) and Ceftazidime-Avibactam (CZA) against Pseudomonas aeruginosa (PSA) from Patients with Cystic Fibrosis (CF)
por: Lasko, Maxwell J, et al.
Publicado: (2020)

P219 Before and during the COVID-19 pandemic: a review of health of our paediatric cystic fibrosis patients
por: Powell, L., et al.
Publicado: (2021)

Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas
por: Evans, Ieuan E. S., et al.
Publicado: (2023)

ePS5.01 Cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity
por: Lausen, M., et al.
Publicado: (2022)

492: CF innate immune defect affects CF intestinal microbiota
por: Scull, C., et al.
Publicado: (2021)

The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial
por: Ronchetti, Katherine, et al.
Publicado: (2018)

235: COVID-19 vaccination in individuals with cystic fibrosis at a pediatric cystic fibrosis center
por: Elson, E., et al.
Publicado: (2021)

P223 The role of psychologist in a cystic fibrosis centre during the COVID-19 pandemic – experience of a Polish paediatric centre
por: Borawska-Kowalczyk, U., et al.
Publicado: (2021)

Two cases of non-cystic fibrosis (CF) bronchiectasis with allergic bronchopulmonary aspergillosis
por: De, Hriday, et al.
Publicado: (2016)

1481. Clinical Outcomes of Escherichia coli Infections in Cystic Fibrosis (CF) Patients
por: Edwards, Brett, et al.
Publicado: (2018)

Oral Hygiene and Periodontal Treatment Needs in Adult Patients with Cystic Fibrosis (CF)
por: Hildebrandt, Tomasz, et al.
Publicado: (2022)

Survival and prognosis after assisted ventilation for acute respiratory failure in cystic fibrosis
por: van Gestel, S, et al.
Publicado: (2005)

P214 Clinical course of SARS-CoV-2 infections of paediatric patients with cystic fibrosis– a single retrospective centre experience
por: Sieber, J., et al.
Publicado: (2023)

Respiratory infection rates differ between geographically distant paediatric cystic fibrosis cohorts
por: Ramsey, Kathryn A., et al.
Publicado: (2016)

The impact of telehealth based care on paediatric cystic fibrosis outcomes
por: Rimbaldo, Kristene, et al.
Publicado: (2023)

Improving health literacy of antibiotic use in people with cystic fibrosis (CF)—comparison of the readability of patient information leaflets (PILs) from the EU, USA and UK of 23 CF-related antibiotics used in the treatment of CF respiratory infections
por: Tang, Ka Wah Kelly, et al.
Publicado: (2023)

TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease
por: Steinke, Eva, et al.
Publicado: (2023)

Discrete choice experiment (DCE) to quantify the influence of trial features on the decision to participate in cystic fibrosis (CF) clinical trials
por: Dobra, Rebecca Anne, et al.
Publicado: (2021)

44: Characterizing the COVID-19 pandemic among Canadians living with cystic fibrosis: A Canadian Cystic Fibrosis Registry study
por: Cheng, S., et al.
Publicado: (2021)

ePS4.10 Evaluation of possible adverse events in relationship to the SARS-CoV-2 vaccination in cystic fibrosis patients with or without lung transplantation: a retrospective single-centre case series
por: Gautschi, F., et al.
Publicado: (2022)

58: Seroprevalence of COVID-19 IgG in the cystic fibrosis population
por: Mahan, K., et al.
Publicado: (2021)

383: Cystic fibrosis macrophage function after elexacaftor/tezacaftor/ivacaftor initiation
por: Zhang, S., et al.
Publicado: (2021)

299: Stress and mental health in cystic fibrosis 1 year after the COVID pandemic: Findings from an Italian sample
por: Graziano, S., et al.
Publicado: (2021)

ROCK STUDY in CF: sustained anti-inflammatory effects of lumacaftor–ivacaftor in sputum and peripheral blood samples of adult patients with cystic fibrosis—an observational study
por: Arooj, Parniya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cirhejb5cc65ufigagp3dni8p8